Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence Skip to content The CRC Digest Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence A review of current evidence suggests circulating tumor DNA has significant prognostic and predictive potential for detecting minimal residual disease and individualizing adjuvant therapy in colorectal cancer. (Klinická Onkologie) This content is informational only
ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery Skip to content The CRC Digest ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery Scoping review examines how circulating tumor DNA can guide adjuvant therapy decisions and surveillance strategies in resected CRC. (Journal of Gastrointestinal Surgery) This content is informational only and does not constitute medical